Browse Related Topics For:

Generic Drugs The United States Food and Drug Administration

45
Pharmaceutical
28
Pharmaceutical Manufacturers
25
Prescription Drugs
22
Patents
21
Pharmaceutical Patents
18
ANDA
18
SCOTUS
13
Preemption
12
Hatch-Waxman
11
Drug Manufacturers
10
Biosimilars
10
Labeling
9
FDCA
8
Failure To Warn
8
Patent Infringement
7
Patent Litigation
7
Reverse Payment Settlement Agreements
6
Warning Labels
5
Affordable Care Act
5
Antitrust Litigation
5
Appeals
5
Design Defects
5
Healthcare
5
Manufacturers
5
Medical Devices
4
BPCIA
4
FTC v Actavis
4
Mutual Pharmaceuticals v Bartlett
4
PLIVA v Mensing
4
Popular
4
Teva Pharmaceuticals
3
FTC
3
GDUFA
3
Medicaid
3
Orphan Drugs
3
Otsuka Pharmaceutical
3
Pharmacies
3
Watson Pharmaceuticals
2
Apotex
2
Biologics Price Competition and Innovation Act of 2009
2
China
2
Class Action
2
Corporate Counsel
2
Duty to Deal
2
Food Safety
2
Healthcare Reform
2
Mensing
2
Mylan Pharmaceuticals
2
Prior Art
2
Product Hopping
2
Professional Conferences
2
Proposed Regulation
2
Safe Harbors
2
Sandoz
2
Trademarks
2
Unfair Competition
1
Abbott Laboratories
1
Actavis
1
Actavis Inc.
1
Advanced Premium Tax Credits
1
Amended Complaints
1
Amgen
1
Antitrust Provisions
1
Approval
1
AstraZeneca
1
Australia
1
Biogen Idec
1
Biopharmaceutical
1
Books
1
BPCI
1
Brand
1
Burden of Proof
1
CA Supreme Court
1
Canada
1
Cartwright Act
1
CDC
1
Cipro
1
Citizen Petitions
1
Classen Immunotherapies
1
Clinical Trials
1
CMS
1
Competition
1
Contraceptive Coverage Mandate
1
Copyright
1
Copyright Infringement
1
Cost-Sharing
1
Covenant Not to Sue
1
Daiichi Sankyo
1
DaimlerAG
1
Declaratory Judgments
1
Defect
1
Dietary Supplements
1
DOHA
1
DOJ
1
DQSA
1
Draft Guidance
1
Drug Compounding
1
Drug Safety
1
EHR
1
Enforcement
1
EU
1
Exceptional Case
1
Exclusivity
1
Exports
1
False Advertising
1
False Claims Act
1
First Sale Doctrine
1
Food Labeling
1
Foreign Manufacturers
1
Generic
1
Gilead Sciences
1
GlaxoSmithKline
1
Government Investigations
1
HHS
1
Highmark v. Allcare
1
Hoffman LaRoche
1
Imports
1
Information Reports
1
Informed Consent
1
Intellectual Property Litigation
1
International Treaties
1
Jurisdiction
1
Justiciable Controversy
1
Kickbacks
1
Legislative Agendas
1
Licenses
1
Life Sciences
1
Manufacturing Defects
1
Medical Device Amendments
1
Medicare
1
MedPAC
1
Medtronic
1
Medtronics
1
Misrepresentation
1
Monopolization
1
Mootness
1
Naming Conventions
1
New Guidance
1
New Regulations
1
NIH
1
Nike
1
Non-Grandfathered Health Plans
1
Novartis
1
Nursing Homes
1
Nutritional Supplements
1
Octane Fitness v. ICON
1
OIG
1
Patent Applications
1
Patent-in-Suit
1
Pay-For-Delay
1
PHRMA
1
Preliminary Injunctions
1
Premarket Approval Applications
1
Product Labels
1
Proposed Legislation
1
Public Meetings
1
Public Performance Rights
1
Putative Class Actions
1
Qui Tam
1
Rebates
1
Recordkeeping Requirements
1
Rule-of-Reason Analysis
1
Rulemaking Process
1
Settlement
1
Sherman Act
1
Standard of Review
1
Standing
1
Summary Judgment
1
Tax Credits
1
Trade Secrets
1
Transfer of Venue
1
Veterinary Products
1
Whistleblowers
1
Women's Preventable Healthcare Mandates
1
WTO
1
Wyeth